Skip to main content
Erschienen in: Endocrine 1/2014

01.05.2014 | Original Article

Obesity modifies expression profiles of metabolic markers in superficial and deep subcutaneous abdominal adipose tissue depots

verfasst von: Gillian E. Walker, Paolo Marzullo, Flavia Prodam, Gianni Bona, Anna Maria Di Blasio

Erschienen in: Endocrine | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

While visceral adipose tissue (VAT) associates to obesity, there is debate for subcutaneous adipose tissue (SAT). One explanation may be SAT subcompartments, superficial-SAT (sSAT) and deep-SAT (dSAT), recently recognized as independent depots. Our aim was to establish roles for sSAT/dSAT with obesity by examining the expression of proteins key to adipocyte metabolism. Paired biopsies from sSAT and dSAT of 10 normal-weight (BMI 21.8 ± 0.8 kg/m2) and 11 obese subjects (BMI 44 ± 2.1 kg/m2) were analyzed for differences in insulin sensitivity using adiponectin, GLUT4 and resistin, glucocorticoid metabolism by 11βHSD1 and alterations of the adipokines leptin and TNFα. Between lean and obese subjects, sSAT and dSAT changes for GLUT4, resistin and TNFα were equivalent. Resistin and TNFα increased in both obese SAT sub-compartments; 33-fold (sSAT; P < 0.006) and 18.5-fold (dSAT; P < 0.003) higher resistin, with undetectable in leans to significant TNFα levels in obese. In contrast, GLUT4 showed 5.5-fold (sSAT; P < 0.03) and 7-fold (dSAT; P < 0.03) lower levels in obese, correlating to BMI (r = −0.6423, P = 0.007) and HOMA-IR (r = −0.5882, P = 0.017). Exclusive sSAT-specific differences were observed for adiponectin, leptin, and 11βHSD1. Both sSAT 11βHSD1 and leptin increased in obese, with 11βHSD1 2.5-fold (P = 0.052) and leptin 3.3-fold (P < 0.008) higher, with 11βHSD1 correlating to HOMA-IR (r = 0.5203, P = 0.0323) and leptin to BMI (r = 0.5810, P = 0.01). In contrast, obese had 7-fold (P < 0.02) lower sSAT adiponectin, correlating to BMI (r = −0.5178, P = 0.027) and HOMA-IR (r = −0.4570, P = 0.049). Overall, sSAT and dSAT are distinct abdominal adipose tissue depots with independent metabolic functions. Between the two, sSAT shows clear independent effects that associate to obesity and its metabolic complications.
Literatur
1.
Zurück zum Zitat J. Vague, The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am. J. Clin. Nutr. 4, 20–31 (1956)PubMed J. Vague, The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am. J. Clin. Nutr. 4, 20–31 (1956)PubMed
2.
Zurück zum Zitat B.L. Wajchenberg, Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 21, 697–738 (2000)PubMedCrossRef B.L. Wajchenberg, Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 21, 697–738 (2000)PubMedCrossRef
3.
Zurück zum Zitat J.A. Nazare, J.D. Smith, A.L. Borel, S.M. Haffner, B. Balkau, R. Ross, C. Massien, N. Alméras, J.P. Després, Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the international study of prediction of intra-abdominal adiposity and its relationship with cardiometabolic risk/intra-abdominal adiposity. Am. J. Clin. Nutr. 96, 714–726 (2012)PubMedCrossRef J.A. Nazare, J.D. Smith, A.L. Borel, S.M. Haffner, B. Balkau, R. Ross, C. Massien, N. Alméras, J.P. Després, Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the international study of prediction of intra-abdominal adiposity and its relationship with cardiometabolic risk/intra-abdominal adiposity. Am. J. Clin. Nutr. 96, 714–726 (2012)PubMedCrossRef
4.
Zurück zum Zitat M.J. Lee, Y. Wu, S.K. Fried, Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol. Aspects Med. 34, 1–11 (2013)PubMedCentralPubMedCrossRef M.J. Lee, Y. Wu, S.K. Fried, Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol. Aspects Med. 34, 1–11 (2013)PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat C. Maffeis, R. Manfredi, M. Trombetta, S. Sordelli, M. Storti, T. Benuzzi, R.C. Bonadonna, Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. J. Clin. Endocrinol. Metab. 93, 2122–2128 (2008)PubMedCrossRef C. Maffeis, R. Manfredi, M. Trombetta, S. Sordelli, M. Storti, T. Benuzzi, R.C. Bonadonna, Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. J. Clin. Endocrinol. Metab. 93, 2122–2128 (2008)PubMedCrossRef
6.
Zurück zum Zitat A.A. Bremer, S. Devaraj, A. Afify, I. Jialal, Adipose tissue dysregulation in patients with metabolic syndrome. J. Clin. Endocrinol. Metab. 96, E1782–E1788 (2011)PubMedCentralPubMedCrossRef A.A. Bremer, S. Devaraj, A. Afify, I. Jialal, Adipose tissue dysregulation in patients with metabolic syndrome. J. Clin. Endocrinol. Metab. 96, E1782–E1788 (2011)PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat H.G. Alexander, A.E. Dugdale, Fascial planes within subcutaneous fat in humans. Eur. J. Clin. Nutr. 46, 903–906 (1992)PubMed H.G. Alexander, A.E. Dugdale, Fascial planes within subcutaneous fat in humans. Eur. J. Clin. Nutr. 46, 903–906 (1992)PubMed
9.
Zurück zum Zitat D.E. Kelley, F.L. Thaete, F. Troost, T. Huwe, B.H. Goodpaster, Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 278, E941–E948 (2000)PubMed D.E. Kelley, F.L. Thaete, F. Troost, T. Huwe, B.H. Goodpaster, Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 278, E941–E948 (2000)PubMed
10.
Zurück zum Zitat G.E. Walker, B. Verti, P. Marzullo, G. Savia, M. Mencarelli, F. Zurleni, A. Liuzzi, A.M. Di Blasio, Deep sub-cutaneous adipose tissue (dSAT): a metabolically distinct abdominal adipose depot. Obes. Res. 15, 1933–1943 (2007)CrossRef G.E. Walker, B. Verti, P. Marzullo, G. Savia, M. Mencarelli, F. Zurleni, A. Liuzzi, A.M. Di Blasio, Deep sub-cutaneous adipose tissue (dSAT): a metabolically distinct abdominal adipose depot. Obes. Res. 15, 1933–1943 (2007)CrossRef
11.
Zurück zum Zitat A. Roca-Rivada, J. Alonso, O. Al-Massadi, C. Castelao, J.R. Peinado, L.M. Seoane, F.F. Casanueva, M. Pardo, Secretome analysis of rat adipose tissues shows location-specific roles for each depot type. Proteomics 74, 1068–1079 (2011)PubMedCrossRef A. Roca-Rivada, J. Alonso, O. Al-Massadi, C. Castelao, J.R. Peinado, L.M. Seoane, F.F. Casanueva, M. Pardo, Secretome analysis of rat adipose tissues shows location-specific roles for each depot type. Proteomics 74, 1068–1079 (2011)PubMedCrossRef
12.
Zurück zum Zitat M. Pardo, A. Roca-Rivada, L.M. Seoane, F.F. Casanueva, Obesidomics: contribution of adipose tissue secretome analysis to obesity research. Endocrine 41, 374–383 (2012)PubMedCrossRef M. Pardo, A. Roca-Rivada, L.M. Seoane, F.F. Casanueva, Obesidomics: contribution of adipose tissue secretome analysis to obesity research. Endocrine 41, 374–383 (2012)PubMedCrossRef
13.
Zurück zum Zitat N. Garcia de la Torre, M.A. Rubio, E. Bordiú, L. Cabrerizo, E. Aparicio, C. Hernández, A. Sánchez-Pernaute, L. Díez-Valladares, A. Torres, M. Puente, A.L. Charro, Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. J. Clin. Endocrinol. Metab. 93, 4276–4281 (2008)PubMedCrossRef N. Garcia de la Torre, M.A. Rubio, E. Bordiú, L. Cabrerizo, E. Aparicio, C. Hernández, A. Sánchez-Pernaute, L. Díez-Valladares, A. Torres, M. Puente, A.L. Charro, Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. J. Clin. Endocrinol. Metab. 93, 4276–4281 (2008)PubMedCrossRef
14.
Zurück zum Zitat Y. Matsuzawa, T. Funahashi, T. Nakamura, The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J. Atheroscler. Thromb. 18, 629–639 (2011)PubMedCrossRef Y. Matsuzawa, T. Funahashi, T. Nakamura, The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J. Atheroscler. Thromb. 18, 629–639 (2011)PubMedCrossRef
15.
Zurück zum Zitat E. Carvalho, K. Kotani, O.D. Peroni, B.B. Kahn, Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am. J. Physiol. Endocrinol. Metab. 89, E551–E561 (2005)CrossRef E. Carvalho, K. Kotani, O.D. Peroni, B.B. Kahn, Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am. J. Physiol. Endocrinol. Metab. 89, E551–E561 (2005)CrossRef
16.
Zurück zum Zitat A. Marette, P. Mauriège, B. Marcotte, C. Atgié, C. Bouchard, G. Thériault, L.J. Bukowiecki, P. Marceau, S. Biron, A. Nadeau, J.P. Després, Regional variation in adipose tissue insulin action and GLUT4 glucose transporter expression in severely obese premenopausal women. Diabetologia 40, 590–598 (1997)PubMedCrossRef A. Marette, P. Mauriège, B. Marcotte, C. Atgié, C. Bouchard, G. Thériault, L.J. Bukowiecki, P. Marceau, S. Biron, A. Nadeau, J.P. Després, Regional variation in adipose tissue insulin action and GLUT4 glucose transporter expression in severely obese premenopausal women. Diabetologia 40, 590–598 (1997)PubMedCrossRef
17.
Zurück zum Zitat C.M. Steppan, S.T. Bailey, S. Bhat, E.J. Brown, R.R. Banerjee, C.M. Wright, H.R. Patel, R.S. Ahima, M.A. Lazar, The hormone resistin links obesity to diabetes. Nature 409, 292–293 (2001)CrossRef C.M. Steppan, S.T. Bailey, S. Bhat, E.J. Brown, R.R. Banerjee, C.M. Wright, H.R. Patel, R.S. Ahima, M.A. Lazar, The hormone resistin links obesity to diabetes. Nature 409, 292–293 (2001)CrossRef
18.
Zurück zum Zitat R.Z. Yang, Q. Huang, A. Xu, J.C. McLenithan, J.A. Eisen, A.R. Shuldiner, S. Alkan, D.W. Gong, Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem. Biophys. Res. Commun. 310, 927–935 (2003)PubMedCrossRef R.Z. Yang, Q. Huang, A. Xu, J.C. McLenithan, J.A. Eisen, A.R. Shuldiner, S. Alkan, D.W. Gong, Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem. Biophys. Res. Commun. 310, 927–935 (2003)PubMedCrossRef
19.
Zurück zum Zitat P.M. Stewart, J.W. Tomlinson, Cortisol, 11 beta-hydroxysteroid dehydrogenase type 1 and central obesity. Trends Endocrinol. Metab. 13, 94–96 (2002)PubMedCrossRef P.M. Stewart, J.W. Tomlinson, Cortisol, 11 beta-hydroxysteroid dehydrogenase type 1 and central obesity. Trends Endocrinol. Metab. 13, 94–96 (2002)PubMedCrossRef
20.
Zurück zum Zitat E.E. Kershaw, N.M. Morton, H. Dhillon, L. Ramage, J.R. Seckl, J.S. Flier, Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 54, 1023–1031 (2005)PubMedCentralPubMedCrossRef E.E. Kershaw, N.M. Morton, H. Dhillon, L. Ramage, J.R. Seckl, J.S. Flier, Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 54, 1023–1031 (2005)PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat N.M. Morton, J.M. Paterson, H. Masuzaki, M.C. Holmes, B. Staels, C. Fievet, B.R. Walker, J.S. Flier, J.J. Mullins, J.R. Seckl, Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53, 931–938 (2004)PubMedCrossRef N.M. Morton, J.M. Paterson, H. Masuzaki, M.C. Holmes, B. Staels, C. Fievet, B.R. Walker, J.S. Flier, J.J. Mullins, J.R. Seckl, Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53, 931–938 (2004)PubMedCrossRef
22.
Zurück zum Zitat M. Wamil, J.H. Battle, S. Turban, T. Kipari, D. Seguret, R. de Sousa Peixoto, Y.B. Nelson, D. Nowakowska, D. Ferenbach, L. Ramage, K.E. Chapman, J. Hughes, D.R. Dunbar, J.R. Seckl, N.M. Morton, Novel fat depot–specific mechanisms underlie resistance to visceral obesity and inflammation in 11β-hydroxysteroid dehydrogenase type 1–deficient mice. Diabetes 60, 1158–1167 (2011)PubMedCentralPubMedCrossRef M. Wamil, J.H. Battle, S. Turban, T. Kipari, D. Seguret, R. de Sousa Peixoto, Y.B. Nelson, D. Nowakowska, D. Ferenbach, L. Ramage, K.E. Chapman, J. Hughes, D.R. Dunbar, J.R. Seckl, N.M. Morton, Novel fat depot–specific mechanisms underlie resistance to visceral obesity and inflammation in 11β-hydroxysteroid dehydrogenase type 1–deficient mice. Diabetes 60, 1158–1167 (2011)PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat M. Cnop, M.J. Landchild, J. Vidal, P.J. Havel, N.G. Knowles, D.R. Carr, F. Wang, R.L. Hull, E.J. Boyko, B.M. Retzlaff, C.E. Walden, R.H. Knopp, S.E. Kahn, The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments. Diabetes 51, 1005–1015 (2002)PubMedCrossRef M. Cnop, M.J. Landchild, J. Vidal, P.J. Havel, N.G. Knowles, D.R. Carr, F. Wang, R.L. Hull, E.J. Boyko, B.M. Retzlaff, C.E. Walden, R.H. Knopp, S.E. Kahn, The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments. Diabetes 51, 1005–1015 (2002)PubMedCrossRef
24.
Zurück zum Zitat Y.L. Cao, C.Z. Hu, X. Meng, D.F. Wang, J. Zhang, Expression of TNF-alpha protein in omental and subcutaneous adipose tissue in obesity. Diabetes Res. Clin. Pract. 79, 214–219 (2008)PubMedCrossRef Y.L. Cao, C.Z. Hu, X. Meng, D.F. Wang, J. Zhang, Expression of TNF-alpha protein in omental and subcutaneous adipose tissue in obesity. Diabetes Res. Clin. Pract. 79, 214–219 (2008)PubMedCrossRef
25.
Zurück zum Zitat H. Gottschling-Zeller, M. Birgel, D. Scriba, W.F. Blum, H. Hauner, Depot-specific release of leptin from subcutaneous and omental adipocytes in suspension culture: effect of tumor necrosis factor-alpha and transforming growth factor-beta1. Eur. J. Endocrinol. 141, 436–442 (1999)PubMedCrossRef H. Gottschling-Zeller, M. Birgel, D. Scriba, W.F. Blum, H. Hauner, Depot-specific release of leptin from subcutaneous and omental adipocytes in suspension culture: effect of tumor necrosis factor-alpha and transforming growth factor-beta1. Eur. J. Endocrinol. 141, 436–442 (1999)PubMedCrossRef
26.
Zurück zum Zitat A.S. Lihn, B. Richelsen, S.B. Pedersen, S.B. Haugaard, G.S. Rathje, S. Madsbad, O. Andersen, Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. Am. J. Physiol. Endocrinol. Metab. 285, E1072–E1080 (2003)PubMed A.S. Lihn, B. Richelsen, S.B. Pedersen, S.B. Haugaard, G.S. Rathje, S. Madsbad, O. Andersen, Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. Am. J. Physiol. Endocrinol. Metab. 285, E1072–E1080 (2003)PubMed
Metadaten
Titel
Obesity modifies expression profiles of metabolic markers in superficial and deep subcutaneous abdominal adipose tissue depots
verfasst von
Gillian E. Walker
Paolo Marzullo
Flavia Prodam
Gianni Bona
Anna Maria Di Blasio
Publikationsdatum
01.05.2014
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2014
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-0040-x

Weitere Artikel der Ausgabe 1/2014

Endocrine 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.